Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
11-50
employees, estimated range
Backers
1
Band of Angels
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2018 Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Your records read against national treatment guidelines, written in plain language, with an oncology nurse on call. Start for $0.
MednetVenture round $16.5M · 9 yr ago
Mednet is a community where doctors find answers to medicine's toughest questions, grounded in the clinical judgment and reasoning of…
OncoLens is the multidisciplinary cancer care platform for tumor boards, registry automation, AI patient identification, and oncology…
Our vision is to give everyone diagnosed with cancer, their best chance to become cancer free. Our mission is to allow no tumour to go…
Neosoma11-50 employees
Better InsightsEmpower Better Care.. Neosoma maps, measures, tracks, and consolidates longitudinal lesion data through a powerful cloud…
ZenOnco.io, India’s first integrative oncology cancer care center. Complete cancer treatment by mainstream, complementary, and alternative…

Overview

Lightening the burden of oral mucositis. Clinical findings showed fewer patients developing severe OM, fewer days with severe OM and less pain, along with favorable findings in treatment continuity.

News

Press release PRNewswire 3 days ago
Mureva Phototherapy and Siemens Healthineers Announce U.S. Co-Marketing Agreement to Expand Access to the First FDA-Authorized Device for Radiation-Induced Oral Mucositis
/PRNewswire-PRWeb/ -- Collaboration brings radiation oncology practices a practical way to deliver global guideline-recommended photobiomodulation to head and...
Read more
Report
Blog 19 days ago
Mureva Announces FDA De Novo Authorization and Peer-Reviewed Publication of Pivotal Mureva OM Trial
Randomized, sham-controlled trial shows Mureva OM significantly reduced severe oral mucositis BRECKSVILLE, Ohio, September 10th, 2026- Mureva Phototherapy Inc. today announced that the U.S. Food and Drug Administration (FDA) granted De Novo authorization
Read more
Report
Blog 9 months ago
American Medical Association Establishes Category III CPT Code for Procedure Associated with the Use of Mureva Phototherapy's LED-based Photobiomodulation Therapy Device
Obtaining this CPT code is an initial step to achieving reimbursement for the use of MuReva Phototherapy's Photobiomodulation Therapy Device when it becomes commercially available Brecksville, Ohio (December 16, 2025) - Mureva Phototherapy, an emerging le
Read more
Report
Pro access
Upgrade to see all 13 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.